[{"id":4,"title":"Approved Through 6\/2021","states_id":42,"description":"SUD-Related Waiver Amendment Request Undergoing CMS Review","first_heading":"TennCare II","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Tennessee","medicad":[{"description":"<ul>\r\n\t<li>Most recent waiver amendment approved on 2\/1\/2018; demonstration effective 12\/16\/2016 through 6\/30\/2021<\/li>\r\n\t<li>Waiver amendment request with SUD features submitted to CMS on 5\/25\/2018; undergoing CMS review<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration authorizes state&rsquo;s mandatory MMC program<\/li>\r\n\t<li>Waiver amendment request includes SUD features aligned with November 2017 SMD letter; state proposes offering a full continuum of SUD services and seeks a waiver of the IMD exclusion<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>&nbsp;Integrated MMC products: Majority of Medicaid population<\/li>\r\n\t<li>FFS: Qualified Medicare Beneficiaries and specified low-income Medicare beneficiaries (outside the demonstration)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<p>Not specified<\/p>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n\r\n<ul>\r\n\t<li>Requests waiver for SUD for stays up to 30 days per admission<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>N\/A<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Waiver Amendment Application<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":5,"title":"Approved Through 12\/2021","states_id":47,"description":"test","first_heading":"Washington State Medicaid Transformation Project","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Washington","medicad":[{"description":"<ul>\r\n\t<li>Most recent waiver amendment, which includes SUD features, approved on 7\/17\/2018;demonstration effective 1\/9\/2017 through 12\/31\/2021<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Delivery system demonstration authorizing the state&rsquo;s DSRIP initiative, among other features<\/li>\r\n\t<li>DSRIP initiative includes projects targeted toward the integration of physical and behavioral health services and strategies to address the opioid crisis; projects focusing on physical\/behavioral health integration are part of the state&rsquo;s strategy for transitioning to integrated managed care products by 2020; lead entities are nonprofit organizations convening providers, behavioral health agencies, and CBOs<\/li>\r\n\t<li>Provides federal matching funds for behavioral health-related DSHPs<\/li>\r\n\t<li>Aligns with November 2017 SMD letter; state provides a full continuum of SUD benefitsand has obtained a waiver of the IMD exclusion<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<p>Varies by region:<\/p>\r\n\r\n<ul>\r\n\t<li>Integrated MMC products: Enrollees in two regions of the state; ASO covers SUD crisis services<\/li>\r\n\t<li>In these regions, populations excluded from managed care (e.g., dual eligibles, medically needy, individuals in an IMD, and long-term care residents) obtain SUD services through BH limited-benefit PIHPs<\/li>\r\n\t<li>BH limited-benefit PIHPs: Majority of Medicaid population, with the exception of enrollees living in regions with integrated MMC products<\/li>\r\n\t<li>FFS: AI\/AN population<\/li>\r\n\t<li>State has released an RFP to procure integrated managed care products for remaining regions by 2020<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>SBIRT<\/li>\r\n\t<li>Outpatient services (ASAM 1)*<\/li>\r\n\t<li>Intensive outpatient services (ASAM 2.1)*<\/li>\r\n\t<li>Residential services, including intensive inpatient services, recovery house services, longterm residential services, and youth residential services (ASAM 3.1 and 3.5)*<\/li>\r\n\t<li>Sub-acute detoxification (ASAM 3.2-WM)*<\/li>\r\n\t<li>Acute detoxification (ASAM 3.7-WM)*<\/li>\r\n\t<li>Acute hospital detoxification (ASAM 4-WM)*<\/li>\r\n\t<li>MAT\/opioid treatment program*<\/li>\r\n\t<li>MAT\/office-based opioid treatment program*<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n\r\n<ul>\r\n\t<li>Obtained waiver for SUD<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>See key SUD-related provisions above<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval and SUD Implementation Plan; Washington State Health Care<br \/>\r\nAuthority RFP 2019\/2020 Integrated Managed Care; 1915(b) Washington State Integrated<br \/>\r\nCommunity Behavioral Health Program Waiver; Apple Health Managed Care<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":6,"title":"Approved Through 12\/2019","states_id":46,"description":"test","first_heading":"Virginia Governor\u2019s Access Plan (GAP) for the Seriously Mentally Ill and Addiction and Recovery Treatment Services (ARTS) Delivery System Transformation Demonstration","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Virginia","medicad":[{"description":"<p>Waiver amendment with SUD features approved on 9\/22\/2017; demonstration effective<br \/>\r\n1\/12\/2015 through 12\/31\/2019<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<p>BH-focused demonstration with two primary components:<\/p>\r\n\r\n<ul>\r\n\t<li>GAP: Expands limited Medicaid benefits to childless adults and noncustodial parents with SMI ages 21&ndash;64 with incomes up to 100% FPL<\/li>\r\n\t<li>ARTS: Implements SUD features aligned with July 2015 SMD letter; state provides a full continuum of SUD benefits and has obtained a waiver of the IMD exclusion<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>&nbsp;Integrated MMC plans: Majority of Medicaid population<\/li>\r\n\t<li>&nbsp;BH service administrator: Individuals enrolled in GAP and populations excluded from managed care, including individuals residing in an ICF\/IID or long-term care facility<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>SUD case management&nbsp;<\/li>\r\n\t<li>Crisis intervention<\/li>\r\n\t<li>&nbsp;SBIRT (ASAM 0.5)&nbsp;<\/li>\r\n\t<li>Outpatient services (ASAM 1)<\/li>\r\n\t<li>&nbsp;Peer recovery supports (ASAM 1)<\/li>\r\n\t<li>SUD intensive outpatient services(ASAM 2.1)<\/li>\r\n\t<li>&nbsp;SUD partial hospitalization (ASAM 2.5)<\/li>\r\n\t<li>&nbsp;Clinically managed low-intensity residential services (ASAM 3.1)^*<\/li>\r\n\t<li>&nbsp;Clinically managed population-specific high-intensity residential services (ASAM 3.3)^*&nbsp;<\/li>\r\n\t<li>&nbsp;Clinically managed high-intensity residential services (ASAM 3.5)^*<\/li>\r\n\t<li>&nbsp;Medically monitored intensive inpatient services (ASAM 3.7)*<\/li>\r\n\t<li>Medically managed intensive inpatient services (ASAM 4)<\/li>\r\n\t<li>Opioid treatment program<\/li>\r\n\t<li>Office-based opioid treatment program<\/li>\r\n\t<li>&nbsp;Withdrawal management services<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes&nbsp;<\/p>\r\n\r\n<ul>\r\n\t<li>Obtained waiver for SUD<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<ul>\r\n\t<li>Individuals in GAP receive limited-benefit package including outpatient hospital coverage, outpatient medical services, MH case management, outpatient individual and group therapies, prescription drugs, and certain SUD services, among others; benefit package is not considered minimum essential coverage<\/li>\r\n\t<li>&nbsp;Individuals in GAP have 12 months&rsquo; continuous coverage<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Original Waiver Application; ARTS Waiver Amendment Application<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":13,"title":"Waiver Request Undergoing CMS Review","states_id":2,"description":null,"first_heading":"Behavioral Health Demonstration","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Alaska","medicad":[{"description":"Waiver request submitted to CMS on 1\/31\/2018","description2":"undergoing CMS review","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\n\t<li>&nbsp;BH-focused waiver request focused on expansion of SUD and MH benefits for three target\npopulations:<\/li>                                                                o Population #1: Children, adolescents, and parents\/caretakers with or at risk of a MH\ndisorder or SUD\no Population #2: Individuals ages 18-64 with acute MH needs\no Population #3: Adolescents and adults ages 12-64 with SUDs\n\t<li>Proposes offering enhanced SUD and\/or MH benefits for covered populations<\/li>   <li>Includes SUD features aligned with November 2017 SMD letter; state proposes offering a\nfull continuum of SUD services and seeks a waiver of the IMD exclusion<\/li>\n<\/ul>","description2":"","medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul><li>FFS administered by ASO: New enhanced BH services covered through demonstration\n(state has not yet contracted with ASO)\n<\/li> <li> FFS: All other BH services (outside the demonstration)<\/li>","description2":"","medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<p>Proposed enhanced benefits include:<\/p>\r\n\r\n<ul>\r\n\t<li>Community and recovery support services^<\/li>\r\n\t<li>Intensive case management services^<\/li>\r\n\t<li>Mobile crisis response services^<\/li>\r\n\t<li>23-hour crisis stabilization services^ (population #1 only)<\/li>\r\n\t<li>Crisis stabilization and observation services^ (population #1 only)<\/li>\r\n\t<li>Crisis residential stabilization services^ (population #1 only)<\/li>\r\n\t<li>Peer-based crisis intervention services^ (population #3 only)<\/li>\r\n\t<li>Early intervention (SBIRT)<\/li>\r\n\t<li>MAT (ASAM 1)^ (population #3 only)<\/li>\r\n\t<li>Outpatient MAT care coordination^ (population #3 only)<\/li>\r\n\t<li>Evidence-based screenings and assessments (ASAM 0.5)^<\/li>\r\n\t<li>Intensive outpatient services (ASAM 2.1) (population #3 only)<\/li>\r\n\t<li>Residential treatment services (including ASAM 3.3)^<\/li>\r\n\t<li>Clinically managed high-intensity residential services--adults (ASAM 3.5)<\/li>\r\n\t<li>Clinically managed medium-intensity services--youth (ASAM 3.5)^<\/li>\r\n\t<li>Ambulatory withdrawal management without extended on-site monitoring (ASAM 1- WM)^ (population #3 only)<\/li>\r\n\t<li>Ambulatory withdrawal management with extended on-site monitoring (ASAM 2-WM)^ (population #3 only)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"Yes\n&#8226; Requests waiver for MH and SUD ","description2":"","medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"Seeks to offer enhanced MH benefit package, including MH day treatment, ACT, and\ntherapeutic foster care services, for populations #1 and #2 ","description2":"","medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"Original Waiver Application","description2":"","medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":14,"title":"Approved Through 12\/2020","states_id":3,"description":"SUD-Related Amendment Request Undergoing CMS Review","first_heading":"Arizona Health Care Cost Containment System: Institutions for Mental Disease Amendment","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Arizona","medicad":[{"description":"<ul>\n\t<li>&nbsp;Most recent waiver amendment (without SUD features) approved on 12\/29\/2017; demonstration effective 10\/1\/2016 through 9\/30\/2021<\/li>\n\t<li>Waiver amendment request with SUD features submitted to CMS on 5\/3\/2017; undergoing CMS review<\/li>\n<\/ul>","description2":"","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\n\t<li>&nbsp;Most recent waiver amendment (without SUD features) approved on 12\/29\/2017; demonstration effective 10\/1\/2016 through 9\/30\/2021<\/li>\n\t<li>Waiver amendment request with SUD features submitted to CMS on 5\/3\/2017; undergoing CMS review<\/li>\n<\/ul>","description2":"","medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul> <li>  Integrated MMC plans: Majority of Medicaid population<\/li>\n<li> FFS: AI\/AN population that opts out of managed care<\/li><\/ul>","description2":"","medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<p>Proposed enhanced benefits include:<\/p>\r\n\r\n<ul>\r\n\t<li>&nbsp;Community and recovery support services^<\/li>\r\n\t<li>Intensive case management services^<\/li>\r\n\t<li>Mobile crisis response services^<\/li>\r\n\t<li>23-hour crisis stabilization services^ (population #1 only)<\/li>\r\n\t<li>&nbsp;Crisis stabilization and observation services^ (population #1 only)<\/li>\r\n\t<li>&nbsp;Crisis residential stabilization services^ (population #1 only)<\/li>\r\n\t<li>Peer-based crisis intervention services^ (population #3 only)<\/li>\r\n\t<li>&nbsp;Early intervention (SBIRT) \uf0a7 MAT (ASAM 1)^ (population #3 only)<\/li>\r\n\t<li>Outpatient MAT care coordination^ (population #3 only)<\/li>\r\n\t<li>&nbsp;Evidence-based screenings and assessments (ASAM 0.5)^<\/li>\r\n\t<li>Intensive outpatient services (ASAM 2.1) (population #3 only) \uf0a7 Residential treatment services (including ASAM 3.3)^<\/li>\r\n\t<li>&nbsp;Clinically managed high-intensity residential services&mdash;adults (ASAM 3.5)^<\/li>\r\n\t<li>Clinically managed medium-intensity services&mdash;youth (ASAM 3.5)^<\/li>\r\n\t<li>Ambulatory withdrawal management without extended on-site monitoring (ASAM 1- WM)^ (population #3 only)<\/li>\r\n\t<li>&nbsp;Ambulatory withdrawal management with extended on-site monitoring (ASAM 2-WM)^ (population #3 only)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"Yes\n<ul><li> Requests waiver for BH; does not specify if request applies to both SUD and MH services<\/li><\/ul>","description2":"","medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"Approved demonstration authorizes specialized, integrated managed care products for\nenrollees with SMI","description2":"","medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"Demonstration Approval Waiver Amendment Application","description2":"","medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":15,"title":"Approved Through 12\/2020","states_id":5,"description":null,"first_heading":"California Medi-Cal 2020","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"California","medicad":[{"description":"<ul><li> Most recent waiver amendment (without SUD features) approved on 12\/22\/2017;\ndemonstration effective 12\/30\/2015 through 12\/31\/2020<\/li>\n<li> Waiver amendment with SUD features approved on 8\/13\/2015<\/li><\/ul>","description2":"","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul><li> Delivery system reform demonstration that authorizes, among other features:\no SUD initiative called Drug Medi-Cal Organized Delivery System (DMC-ODS), which\naligns with July 2015 SMD letter; State provides a full continuum of SUD benefits and\nhas obtained a waiver of the IMD exclusion<\/li>\n<li> DMC-ODS provides both State Plan benefits and benefits newly authorized under\nthe demonstration<\/li>\n<li> Counties have the option of participating in DMC-ODS\n<\/li><li> The full range of DMS-ODS benefits (see below) are only available to Medicaid\nenrollees<li> residing in a participating county; the more limited State Plan SUD\nbenefit package is available in non-participating counties\no Public Hospital Redesign & Incentives in Medi-Cal (PRIME), a follow-up to State???s DSRIP\ninitiative authorized under an earlier version of the demonstration<\/li>\n<li> Includes projects to be implemented through designated public hospital systems\nand district\/municipal public hospitals targeted toward addressing primary\ncare\/behavioral health integration\no Whole Person Care (WPC) Pilots<\/li>\n<li> Designed to coordinate physical health, behavioral health, and social services\nthrough collaboration among county agencies, health plans, and providers with a\nfocus on vulnerable populations<\/li>\n<li> May be led by a city, a county, a city and county, a health or hospital authority, or\na consortium of cities, counties, and\/or health or hospital authorities\n<\/li> <li> Provide access to interventions that would not otherwise be covered by Medicaid\n(e.g., tenancy-based care management services, county housing pools to support\nmedically necessary housing services, etc.)\n<\/li><li> May select individuals with SUDs or MH disorders as a target population<\/li>","description2":"","medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"&#8226;  County-operated BH limited-benefit PIHPs: All DMC-ODS benefits in DMC-ODS\nparticipating counties\n&#8226; FFS:\no In counties that are not participating in DMC-ODS: All State Plan SUD benefits\no In counties participating in DMC-ODS: Medically monitored inpatient services,\nmedically managed intensive inpatient services, medically monitored inpatient\nwithdrawal management, medically managed intensive inpatient withdrawal\nmanagement, medically managed intensive inpatient withdrawal management, and\nSBIRT for populations for populations excluded from managed care (services not\ncovered by BH limited-benefit PIHPs; excluded populations vary by county)\n&#8226; MMC plans providing physical health services: In all counties, provide medically monitored\ninpatient services, medically managed intensive inpatient services, medically monitored\ninpatient withdrawal management, medically managed intensive inpatient withdrawal\nManagement, medically managed intensive inpatient withdrawal management, and SBIRT\n(services not covered by BH limited-benefit PIHPs) to individuals enrolled in MMC for\nphysical health services","description2":"? Waiver amendment request includes SUD\nfeatures aligned with November 2017 SMD\nletter; state offers a full continuum of SUD\nservices and seeks a waiver of the IMD\nExclusion","medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"DMC-ODS benefits:<ul>\n<li> Early intervention (SBIRT) (ASAM 0.5)<\/li>\n<li> Outpatient drug-free treatment services (ASAM 1)<\/li>\n<li> Intensive outpatient services (ASAM 2.1)<\/li>\n<li> Partial hospitalization (optional; counties do not have to offer service) (ASAM 2.5)^<\/li>\n<li> Residential treatment services: counties are initially required to provide at least one of the\nASAM levels below; within three years, they must provide all ASAM levels\no Clinically managed low-intensity residential services (ASAM 3.1)^*\no Clinically managed population-specific high-intensity residential services (ASAM 3.3)^*\no Clinically managed high-intensity residential services (ASAM 3.5)^*\n<li> Withdrawal management services: counties are required to provide at least one of the\nfollowing ASAM levels<\/li>\no Ambulatory withdrawal management without extended on-site monitoring (ASAM 1-\nWM)\no Ambulatory withdrawal management with extended on-site monitoring (ASAM 2-WM)\no Clinically managed residential withdrawal management (ASAM 3.2-WM)\n<li> Medically monitored inpatient services (ASAM 3.7) (provided via MMC plan or FFS)*<\/li>\n<li> Medically managed intensive inpatient services (ASAM 4) (provided via MMC plan or FFS)*<\/li>\n<li> Medically monitored inpatient withdrawal management (ASAM 3.7-WM) (provided via\nMMC plan or FFS)*<\/li>\n<li> Medically managed intensive inpatient withdrawal management (ASAM 4-WM) (provided\nvia MMC plan or FFS)*<\/li>\n<li> Narcotic treatment program\/opioid treatment program (methadone, buprenorphine,\ndisulfiram, and naloxone)<\/li>\n<li> MAT<\/li>\n<li> Recovery services^<\/li>\n<li> Case management^<\/li>\n<li> Physician consultation<\/li><\/ul>\nState Plan benefits:\n<ul><li> Early intervention (SBIRT) (ASAM 0.5)<\/li>\n<li> Outpatient drug-free treatment services (ASAM 1)<\/li>\n<li> Intensive outpatient services (ASAM 2.1)<\/li>\n<li> Residential treatment services (for perinatal population only)<\/li>\n<li> Medically monitored inpatient services (ASAM 3.7)<\/li>\n<li> Medically managed intensive inpatient services (ASAM 4)<\/li>\n<li> Medically monitored inpatient withdrawal management (ASAM 3.7-WM)<\/li>\n<li> Medically managed intensive inpatient withdrawal management (ASAM 4-WM)<\/li>\n<li> Narcotic treatment program (methadone only)<\/li>\n<li> MAT<\/li>\n<li> Targeted case management (not available statewide)<\/li>","description2":"","medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"Yes <ul><li>Obtained waiver for SUD for counties participating in DMC-ODS<\/li>  <li>Length of stay limited to two nonconsecutive 90-day stays per year for adults and two\nnonconsecutive 30-day stays per year for adolescents; length of stay for criminal justice\noffenders can be up to six consecutive months <\/li><\/ul>","description2":"","medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"See information above regarding PRIME and WPC Pilots","description2":"","medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"Demonstration Approval; Original Waiver Application; County Organized Health Systems\nBoilerplate Contract; Medi-Cal Moves Addiction Treatment into the Mainstream: Early\nLessons from the DMC-ODS Pilots","description2":"","medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":16,"title":"Approved Through 12\/2018","states_id":8,"description":"SUD-Related Amendment Request Undergoing CMS Review","first_heading":"Delaware Diamond State Health Plan","second_heading":"Proposed Changes in Delaware Diamond StateHealth Plan Amendment","state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Delaware","medicad":[{"description":"<ul> <li>  Most recent waiver amendment (without SUD features) approved on 12\/20\/2017 demonstration effective 9\/30\/2013 through\n12\/31\/2018<\/li><li>Waiver amendment with SUD features\napproved on 12\/19\/2014<\/li><\/ul>","description2":"<ul><li> Waiver amendment with SUD features\nsubmitted to CMS on 6\/29\/2018;\nundergoing CMS review<\/li><\/ul>","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul><li> Demonstration authorizes State's mandatory MMC program, among other features <\/li><li> Waiver features include Promoting Optimal\nMental Health for Individuals through\nSupports and Empowerment (PROMISE), an\ninitiative targeted toward individuals who\nhave an SPMI or SUD and require HCBS \"to\nlive and work in integrated settings\" <\/li> <li>Individuals enrolled in PROMISE have access to enhanced MH, SUD, and HCBS benefits and a Division of Substance Abuse and Mental Health case manager <\/li><li> MMC plans must ensure coordination between FFS PROMISE benefits and BH benefits provided through MMC plans<\/li><\/ul>","description2":"<ul><li> Waiver amendment request includes SUD\nfeatures aligned with November 2017 SMD\nletter; state offers a full continuum of SUD\nservices and seeks a waiver of the IMD\nExclusion<\/li><\/ul>","medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul><li>  Integrated MMC plans: State Plan BH benefits for majority of Medicaid population <\/li> <li> FFS: o PROMISE enhanced BH benefits for individuals eligible for PROMISE (within demonstration) o All State Plan BH benefits for populations excluded from managed care, including individuals enrolled in PACE, individuals residing in an ICF\/IID, and individuals in the State's I\/DD 1915(c) waiver (outside the demonstration)<\/li><\/ul>","description2":"No proposed changes","medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"PROMISE enhanced benefits for individuals\nwith SUD include:<ul><li> Benefits counseling^<\/li>\n<li> Case management^<\/li>\n<li> Community-based residential alternative\nsupports that exclude assisted living^ <\/li><li> Community transition services^<\/li>\n<li> Financial coaching^<\/li>\n<li> Non-medical transportation^<\/li>\n<li> Nursing^<\/li>\n<li> Peer supports^<\/li>\n<li> Personal care^<\/li>\n<li> Respite^<\/li>\n<li> Skill-building for individual activities of daily\nliving\/chores^<\/li>\n<li> Supported employment (both individual and\nsmall group)^\nOther benefits include:<\/li>\n<li> MAT<\/li>\n<li> Services delivered by BH practitioner<\/li>","description2":"State provides full continuum of SUD services,\nincluding:\n<ul><li> Crisis intervention<\/li>\n<li> Outpatient addiction treatment, including\nMAT<\/li>\n<li> Residential addiction treatment services<\/li><\/ul>","medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"No","description2":"Yes\n<ul><li> Requests waiver for SUD<\/li><\/ul>","medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"PROMISE enhanced MH benefits include community psychiatric support, treatment\/psychosocial rehabilitation, and other services by non-licensed clinical staff including evidence-based practices such as ACT and intensive case management","description2":"No proposed changes","medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"Demonstration Approval; Waiver Amendment\nApplication","description2":"Waiver Amendment Application","medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":17,"title":"Approved Through 6\/2022","states_id":9,"description":"SUD-Related Waiver Amendment Request Undergoing CMS Review","first_heading":"Managed Medical Assistance Program","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Florida","medicad":[{"description":"<ul><li> Most recent waiver extension (without SUD features) approved on 6\/8\/2018;\ndemonstration effective 8\/1\/2017 through 6\/30\/2022<\/li>\n<li> Waiver amendment with SUD features submitted to CMS on 11\/15\/2016; undergoing CMS\nreview<\/li><\/ul>","description2":"","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul><li>Demonstration authorizes state\u2019s mandatory MMC program, among other features\n<\/li><li> Waiver amendment seeks expenditure authority to implement pilot in two regions of the\nstate to expand BH, housing, and tenancy benefits available to individuals ages 21+ with\nSMI, SUD, or co-occurring SMI and SUD who are also homeless or at risk of becoming\nhomeless due to disability\n<\/li><li> Plans participating in pilot would be required to partner with housing providers and local\nhousing coalitions<\/li> <\/ul>","description2":"","medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul><li> Integrated MMC plans: Majority of Medicaid population\n<\/li><li> FFS: Populations exempt or excluded from managed care, including individuals residing in\nan ICF\/IID and medically needy individuals, among others (outside the demonstration)<\/li> <\/ul>","description2":"","medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"Proposed enhanced benefits include:\n<ul><li> Transitional housing services^<\/li>\n<li> Tenancy-sustaining services^<\/li>\n<li> Mobile crisis management^<\/li>\n<li> Self-help peer support^<\/li><\/ul> ","description2":"","medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"No","description2":"","medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"Approved demonstration authorizes specialty managed care plans; one specialty plan focuses\non individuals with SMI","description2":"","medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"Demonstration Approval","description2":" Waiver Amendment Application","medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":18,"title":"Approved Through 12\/2018","states_id":11,"description":"SUD-Related Waiver Amendment Request Undergoing CMS Review","first_heading":"QUEST Integration","second_heading":"","state_content":null,"state_name":"Hawaii","medicad":[{"description":"<ul><li> Most recent waiver amendment (no SUD features) approved on 10\/26\/2015;\ndemonstration effective 10\/1\/2013 through 12\/31\/2018\n<\/li><li> Waiver amendment request with SUD features submitted to CMS on 8\/29\/2017;\nundergoing CMS review<\/li><\/ul>","description2":"","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul><li> Demonstration authorizes state\u2019s mandatory MMC program, among other features\n<\/li><li> Waiver amendment seeks to provide pre-tenancy and tenancy supportive housing services<\/li>\nfor individuals ages 18+ who are any of the following:\no Chronically homeless\no Homeless\/at risk of homelessness and have a severe MH disorder, SUD, or chronic\/\ncomplex health needs\no Homeless\/at risk of homelessness and have frequent ED visits or inpatient hospital\nstays <\/ul>","description2":"","medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul><li> Integrated MMC plans: Majority of Medicaid population\n<\/li><li> BH limited-benefit PIHP: Adults ages 21+ who have SMI or SPMI\n<\/li><li> FFS: Enhanced supportive housing benefits for a limited set of individuals with SUD <\/li><\/ul>","description2":"","medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul><li> Proposed supportive housing benefits include:\n<p>o Pre-tenancy supports (include screening and assessment, development of housing\nsupport plan, assistance with housing search, application preparation and submission,\nand moving assistance, among other services)^<\/p>\n<p>o Tenancy supports (include individual housing and tenancy-sustaining services,\neducation and training, teaching dispute resolution with landlords and neighbors, and\nservice care coordination, among other services)^<\/p><\/li>\n<li> Other current SUD benefits include:\n<p>o Residential SUD services<\/p>\n<p>o Outpatient SUD services<\/p>\n<p>o Methadone treatment<\/p><\/li><\/ul> ","description2":"","medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"No ","description2":"","medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"Approved demonstration authorizes enhanced services, including supportive housing,\nsupportive employment, and financial management services for individuals with SMI and\nSPMI and individuals requiring support for emotional and behavioral disorders","description2":"","medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"Demonstration Approval; Waiver Amendment Application; RFP Community Care Services\nProgram","description2":"","medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":19,"title":"Approved Through 6\/2023","states_id":13,"description":null,"first_heading":"Illinois Behavioral Health Transformation Demonstration","second_heading":null,"state_content":"<p>CMS did not approve a number of SUD-related features requested by Illinois, including expenditure authority to:<br \/>\r\ndevelop and implement integrated physical and behavioral health homes (e.g., funding for provider training and<br \/>\r\ncapacity building); implement BH workforce training and capacity-building initiatives (e.g., loan repayment,<br \/>\r\nincentives to work in underserved areas, telemedicine, etc.); provide select benefits for justice-involved<br \/>\r\npopulations 30 days prior to release; and provide federal matching funds for BH-related DHSPs. Additionally, CMS<br \/>\r\ndid not approve Illinois&rsquo;s waiver requests to delay Medicaid redetermination for justice-involved populations until<br \/>\r\n180 days after release and auto-enroll justice-involved populations in a MMC plan prior to discharge.<br \/>\r\n^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Illinois","medicad":[{"description":"Waiver approved on 5\/7\/2018","description2":" demonstration effective 7\/1\/2018 through 6\/30\/2023 ","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul><li> BH-focused demonstration that authorizes nine BH- and HCBS-related pilot programs<\/li>\n<li> Aligns with November 2017 SMD letter; state provides a full continuum of SUD benefits<\/li>\nand has obtained a waiver of the IMD exclusion\n<li> Provides expenditure authority to implement the following SUD- and\/or MH-related pilots<\/li>\n<p>(pilots have capped enrollment and may not operate statewide):<\/p>\n<p>o Clinically managed withdrawal management services pilot: Covers clinically managed\nwithdrawal management services for up to 11,072 enrollees<\/p>\n<p> o SUD case management pilot: Covers SUD case management services for up to 2,835\nenrollees who qualify for diversion from the criminal justice system<p>\n<p>o Peer recovery support services pilot: Covers peer support services delivered by a\nrecovery coach for up to 320 enrollees with a SUD<\/p>\n<p>o Crisis intervention services pilot: Covers crisis intervention services delivered at acute\ncare hospitals, PRTFs, or community residential treatment centers with <16 beds for up\nto 8,493 enrollees who are experiencing psychiatric crisis<\/p>\n<p>o Evidence-based home visiting services pilot: Covers evidence-based home visits\ndelivered by mental health professionals for up to 1,038 children up to age 5 who were\nborn with withdrawal symptoms and for mothers up to 60 days postpartum whose\nchildren have withdrawal symptoms<\/p>\n<p>o Assistance in community integration services pilot: Covers pre-tenancy supports and\ntenancy-sustaining services for up to 3,750 enrollees who have a significant number of\nED visits\/hospitalizations or two or more chronic conditions and are \u201cat imminent risk\u201d\nof homelessness or institutionalization<\/p>\n<p>o Supported employment services pilot: Covers pre-employment services (e.g., personcentered\nemployment planning, pre-vocational\/job-related discovery or assessment,\netc.) and employment-sustaining services (e.g., career advancement services, job\ncoaching, etc.) for up to 3,375 enrollees with serious and persistent MH needs or SUD\nneeds<\/p>\n<p>o Intensive in-home services pilot: Covers intensive in-home services for up to 18,650\nenrollees ages 3\u201321 who meet the state\u2019s health home eligibility criteria and have\nsignificant BH needs<\/p>\n<p>o Respite services pilot: Covers respite services for up to 3,871 enrollees ages 3\u201321 who\nhave significant MH needs <\/p><\/ul>","description2":"","medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul><li> Integrated MMC plans: Majority of Medicaid population<\/li>\n<li> FFS: Populations excluded from MMC, including AI\/AN population and dual eligibles<\/li><\/ul>","description2":"","medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul><li> Outpatient services<\/li>\n<li> Intensive outpatient services<\/li><li>\n Residential treatment*<\/li><li>\n Medically supervised withdrawal management*<\/li><li>\n MAT*<\/li><li>\n Clinically managed withdrawal management^*<\/li><li>\n SUD case management^*<\/li><li>\n Peer recovery support services^*<\/li><li>\n Evidence-based home visiting services^<\/li><li>\n Assistance in community integration services^<\/li><li>\n Supported employment services^ <\/li><\/ul>","description2":"","medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"Yes\n<ul><li> Obtained waiver for SUD<\/li>\n<li> Requested but did not obtain waiver for MH<\/li><\/ul> ","description2":"","medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"See key SUD-related provisions above ","description2":"","medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"Demonstration Approval Original Waiver Application","description2":"","medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":20,"title":"Approved Through 12\/2020","states_id":14,"description":null,"first_heading":"Healthy Indiana Plan","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Indiana","medicad":[{"description":"<p>Waiver extension with SUD features approved on 2\/1\/2018; demonstration effective 2\/1\/2018 through 12\/31\/2020<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>&nbsp;Demonstration focuses on coverage features<\/li>\r\n\t<li>Includes SUD features aligned with November 2017 SMD letter; state provides a full continuum of SUD benefits and has obtained a waiver of the IMD exclusion<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Integrated MMC plans: Majority of Medicaid population<\/li>\r\n\t<li>FFS: Populations excluded from managed care, such as individuals eligible for HCBS services, dual eligibles, and individuals in nursing homes and ICF\/IIDs (outside the demonstration, with the exception of services provided to individuals in IMDs)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Early intervention (ASAM 0.5)<\/li>\r\n\t<li>Outpatient services (ASAM 1)<\/li>\r\n\t<li>Intensive outpatient services (ASAM 2.1)<\/li>\r\n\t<li>Partial hospitalization (ASAM 2.5)<\/li>\r\n\t<li>Clinically managed low-intensity residential services (ASAM 3.1)^*<\/li>\r\n\t<li>Clinically managed high-intensity residential services (ASAM 3.5)^*<\/li>\r\n\t<li>Medically monitored intensive inpatient services (ASAM 3.7)^*<\/li>\r\n\t<li>Medically managed intensive inpatient services (ASAM 4)*<\/li>\r\n\t<li>Withdrawal management*<\/li>\r\n\t<li>Addiction recovery management services^<\/li>\r\n\t<li>Opioid treatment program*<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n<ul>\r\n\t<li>Obtained waiver for SUD<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>None<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Waiver Extension Application; Amended Waiver Extension Application; SUD Implementation Plan; Summary of Populations Served by Traditional Medicaid<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":21,"title":"Approved Through 12\/2021","states_id":45,"description":null,"first_heading":"Vermont Global Commitment to Health Demonstration","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Vermont","medicad":[{"description":"<p>Most recent waiver amendment, which includes SUD features, approved on 6\/6\/2018;<br \/>\r\ndemonstration effective 1\/1\/2017 through 12\/31\/2021<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>&ldquo;Global waiver&rdquo; encompassing almost entire Medicaid program<\/li>\r\n\t<li>Authorizes mandatory MMC-like program (described in more detail below) and &ldquo;investments&rdquo; in initiatives that increase access to care, improve outcomes, and reduce the uninsured and underinsured populations, among other features<\/li>\r\n\t<li>Approved &ldquo;investments&rdquo; include initiatives related to treating SUD and promoting BH integration<\/li>\r\n\t<li>Aligns with November 2017 SMD letter; state provides a full continuum of SUD benefits and has obtained a waiver of the IMD exclusion<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Entire Medicaid population served by integrated MMC-like plans, where the Medicaid agency contracts with the Department of Vermont Health Access (DVHA) to deliver services<\/li>\r\n\t<li>&nbsp;CMS treats DVHA as a PIHP<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Early intervention SBIRT (ASAM 0.5)<\/li>\r\n\t<li>Outpatient services (ASAM 1)<\/li>\r\n\t<li>Intensive outpatient services (ASAM 2.1)<\/li>\r\n\t<li>Partial hospitalization day treatment, psychosocial rehabilitation services (ASAM 2.5)<\/li>\r\n\t<li>Clinically managed low-intensity residential services (ASAM 3.1)<\/li>\r\n\t<li>Clinically managed population-specific high-intensity residential services (ASAM 3.3)*<\/li>\r\n\t<li>Clinically managed high-intensity residential services (ASAM 3.5)*<\/li>\r\n\t<li>Medically monitored intensive inpatient services (ASAM 3.7)*<\/li>\r\n\t<li>Medically managed intensive inpatient services (ASAM 4)*<\/li>\r\n\t<li>Opioid treatment program<\/li>\r\n\t<li>Withdrawal management services (ASAM 1 to 4-WM)*<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n\r\n<ul>\r\n\t<li>Obtained waiver for SUD<\/li>\r\n\t<li>State has waiver authority to fund MH and SUD services in designated IMDs using managed care savings; by 12\/2018, state must submit plan to phase down these expenditures and must eliminate them by 12\/2025<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<ul>\r\n\t<li>Provides federal matching funds for DSHP provision of MH community rehabilitation and treatment services<\/li>\r\n\t<li>Authorizes HCBS, including service coordination, residential treatment, supported employment, and respite, for individuals &lt;age 21 with SED<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval and SUD Implementation Plan; Waiver Amendment Application<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":22,"title":"Approved Through 6\/2022","states_id":44,"description":null,"first_heading":"Primary Care Network Demonstration","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Utah","medicad":[{"description":"<ul>\r\n\t<li>Most recent waiver amendment, which includes SUD features, approved on 10\/31\/2017; demonstration effective 11\/1\/2017 through 6\/30\/2022<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Broad demonstration authorizing limited coverage expansions to targeted groups<\/li>\r\n\t<li>Expands coverage to childless adults ages 19&ndash;64 with incomes &le;5% FPL who are chronically homeless or in need of SUD or MH treatment (including justice-involved populations); state does not receive ACA&rsquo;s enhanced match for this population<\/li>\r\n\t<li>Aligns with November 2017 SMD letter; state provides a full continuum of SUD benefitsand has obtained a waiver of the IMD exclusion<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>BH limited-benefit PIHPs: Majority of Medicaid population<\/li>\r\n\t<li>Integrated MMC plans: Individuals with I\/DDs enrolled in Healthy Outcomes Medical Excellence program<\/li>\r\n\t<li>FFS covers:<\/li>\r\n\t<li>&nbsp;SUD services for populations excluded from BH limited-benefit PIHPs (e.g., childless adults ages 19&ndash;64 with incomes &le;5% FPL who are chronically homeless or in need of SUD or MH treatment) and populations whose SUD services are carved out of BH limited-benefit PIHPs (e.g., children in foster care)<\/li>\r\n\t<li>&nbsp;SUD services carved out of limited-benefit PIHPs (e.g., methadone maintenance services)<\/li>\r\n\t<li>&nbsp;SUD services that the BH limited-benefit PIHP in a particular county does not cover (e.g., some BH limited-benefit PIHPs do not provide inpatient SUD services; others do not provide outpatient SUD services)<\/li>\r\n\t<li>&nbsp;SUD services for the one county without a BH limited-benefit PIHP<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>&nbsp;Early intervention (SBIRT) (ASAM 0.5)<\/li>\r\n\t<li>&nbsp;Outpatient services (ASAM 1)<\/li>\r\n\t<li>&nbsp;Intensive outpatient services (ASAM 2.1)<\/li>\r\n\t<li>&nbsp;Day treatment\/psychosocial rehabilitation services (ASAM 2.5)<\/li>\r\n\t<li>Clinically managed low-intensity residential services (ASAM 3.1)<\/li>\r\n\t<li>&nbsp;Clinically managed population-specific high-intensity residential services (ASAM 3.3)<\/li>\r\n\t<li>&nbsp;Clinically managed high-intensity residential services (ASAM 3.5)<\/li>\r\n\t<li>Medically monitored intensive inpatient services (ASAM 3.7)<\/li>\r\n\t<li>&nbsp;Medically managed intensive inpatient services (ASAM 4)<\/li>\r\n\t<li>Opioid treatment program<\/li>\r\n\t<li>&nbsp;Ambulatory withdrawal management without extended on-site monitoring (ASAM 1-WM)^<\/li>\r\n\t<li>&nbsp;Ambulatory withdrawal management with extended on-site monitoring (ASAM 2-WM)<\/li>\r\n\t<li>&nbsp;Clinically managed residential withdrawal management (ASAM 3.2-WM)^<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n\r\n<ul>\r\n\t<li>Obtained waiver for SUD Other Notable MH-Related Provisions See key SUD-related provisions<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>See key SUD-related provisions above<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Waiver Extension and Amendment Application; SUD<br \/>\r\nImplementation Plan; 1915(b) Prepaid Mental Health Plan Waiver; Utah Medicaid Provider<br \/>\r\nManual. Section 1: General Information; Utah Medicaid Provider Manual. Section 2:<br \/>\r\nRehabilitative Mental Health and Substance Use Disorder Services<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":23,"title":"Approved Through 12\/2018","states_id":16,"description":"Waiver Extension Request Undergoing CMS Review","first_heading":"KanCare 2.0","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Kansas","medicad":[{"description":"<ul>\r\n\t<li>&nbsp;Waiver approved on 1\/29\/2014; demonstration effective 1\/29\/2014 through 12\/31\/2018<\/li>\r\n\t<li>Waiver extension request with SUD features submitted to CMS on 12\/26\/2017; undergoing CMS review<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration authorizes state&rsquo;s mandatory MMC program and DSRIP initiative, among other features<\/li>\r\n\t<li>Current waiver authorizes enhanced benefits for individuals with SUDs; state seeks continuation of expenditure authority as part of waiver extension<\/li>\r\n\t<li>DSRIP initiative includes projects targeted toward addressing physical\/BH integration and prevention of SUDs; hospitals are lead entities<\/li>\r\n\t<li>Waiver extension request includes SUD features aligned with November 2017 SMD letter; seeks waiver of the IMD exclusion<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Integrated MMC plans: Majority of Medicaid population<\/li>\r\n\t<li>FFS: Populations excluded from MMC, including enrollees in PACE or in long-term institutional care and Qualified Medicare Beneficiaries (outside of demonstration)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<p>Enhanced benefits include SUD rehabilitation services (ASAM 3.1, ASAM 3.3, and ASAM 3.5)^<\/p>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n<ul>\r\n\t<li>Requests waiver for SUD for MMC enrollees<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<p>As part of waiver extension request, state seeks continuation of existing expenditure authority to offer enhanced MH services, including physician consultation and personal care services, to individuals with SPMI and SED<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Waiver Extension Application; Temporary Extension Letter<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":24,"title":"Approved Through 9\/2023","states_id":17,"description":null,"first_heading":"Kentucky Helping to Engage and Achieve Long Term Health (KY HEALTH)","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Kentucky","medicad":[{"description":"<p>Waiver approved on 1\/12\/2018; demonstration effective 1\/12\/2018 through 9\/30\/2023<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration authorizes coverage features and SUD features aligned with November 2017 SMD letter; state provides a full continuum of SUD services and has obtained a waiver of the IMD exclusion<\/li>\r\n\t<li>Waives NEMT for travel to methadone treatment (individuals ages 19&ndash;20, pregnant women, medically frail individuals, and former foster care children are exempt)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Integrated MMC plans: Majority of Medicaid population<\/li>\r\n\t<li>FFS: Populations excluded from managed care, including individuals enrolled in an HCBS waiver, individuals residing in a nursing facility or ICF\/IID, and spend-down populations<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Early intervention (SBIRT)<\/li>\r\n\t<li>Outpatient therapy (individual, group, family, collateral)<\/li>\r\n\t<li>Intensive outpatient program<\/li>\r\n\t<li>Partial hospitalization treatment (including day treatment for children\/youth under the age of 21)<\/li>\r\n\t<li>Residential treatment*<\/li>\r\n\t<li>Medically supervised withdrawal management*<\/li>\r\n\t<li>MAT*<\/li>\r\n\t<li>Methadone treatment for opioid dependence*<\/li>\r\n\t<li>Peer support (including parent\/family peer support)*<\/li>\r\n\t<li>Crisis intervention (including mobile crisis)<\/li>\r\n\t<li>Residential crisis stabilization*<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n<ul>\r\n\t<li>Obtained waiver for SUD<\/li>\r\n\t<li>Requested but did not obtain waiver for MH<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>None<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Original Waiver Application; Kentucky Managed Care Organization Program 1915(b) Waiver<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":25,"title":"Approved Through 12\/2018","states_id":39,"description":"SUD-Related Waiver Extension and Amendment Request Undergoing CMS Review","first_heading":"Rhode Island Comprehensive Demonstration","second_heading":"Amendment to Rhode Island Comprehensive Demonstration","state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Rhode Island","medicad":[{"description":"<ul>\r\n\t<li>Most recent waiver amendment approved on 4\/25\/2018; demonstration effective 12\/23\/2013 through 12\/31\/2018<\/li>\r\n\t<li>Waiver amendment with SUD features approved on 2\/8\/2018<\/li>\r\n<\/ul>","description2":"<ul>\r\n\t<li>Waiver amendment request with SUD features submitted to CMS on 7\/11\/2018; undergoing CMS review<\/li>\r\n<\/ul>","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>&ldquo;Global waiver&rdquo; encompassing almost entire Medicaid program<\/li>\r\n\t<li>Authorizes mandatory MMC, among other features<\/li>\r\n\t<li>Provides expenditure authority for enhanced benefits for individuals with SUDs<\/li>\r\n\t<li>Authorizes federal match for DSHP providing limited benefits to uninsured adults with incomes from 133% to 200% FPL who have a mental illness or SUD<\/li>\r\n<\/ul>","description2":"<ul>\r\n\t<li>Seeks expenditure authority to offer new enhanced BH benefits<\/li>\r\n\t<li>Includes SUD features aligned with November 2017 SMD letter; state proposes offering a full continuum of SUD services and seeks a waiver of the IMD exclusion<\/li>\r\n<\/ul>","medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Integrated MMC plans: Majority of Medicaid population<\/li>\r\n\t<li>&nbsp;FFS: ABD population, including dual eligibles, who opt out of managed care<\/li>\r\n<\/ul>","description2":"<p>No proposed changes<\/p>","medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Recovery navigation program: a &ldquo;nonresidential (&lt;24 hours), community-based recovery-oriented program that assesses, monitors, and provides case management and peer support for individuals who are under the influence of substances&rdquo;^<\/li>\r\n\t<li>Peer recovery specialist services^<\/li>\r\n<\/ul>","description2":"<ul>\r\n\t<li>Proposes offering BH triage center services as an enhanced service; seeks waiver to offer service less than statewide^<\/li>\r\n<\/ul>","medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>No<\/p>","description2":"<p>Yes<\/p>\r\n\r\n<ul>\r\n\t<li>Requests waiver for SUD and MH<\/li>\r\n<\/ul>","medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<ul>\r\n\t<li>Peer recovery specialist services are also available to individuals with mental illness<\/li>\r\n<\/ul>","description2":"<ul>\r\n\t<li>BH triage center services would also be available to enrollees in mental health crisis<\/li>\r\n\t<li>&nbsp;Seeks expenditure authority to offer peer mentoring services and provide reimbursement for telephonic psychiatric consultation to primary care providers<\/li>\r\n<\/ul>","medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Rhode Island<br \/>\r\nComprehensive Section 1115 Demonstration<br \/>\r\nFact Sheet<\/p>","description2":"<p>Waiver Extension and Amendment Application<\/p>","medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":26,"title":"Approved Through 12\/2022","states_id":18,"description":null,"first_heading":"Healthy Louisiana Opioid Use Disorder\/Substance Use Disorder","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Louisiana","medicad":[{"description":"<p>Waiver with SUD features approved on 2\/1\/2018; demonstration effective 2\/1\/2018 through 12\/31\/2022<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<p>SUD-focused demonstration aligned with November 2017 SMD letter; state provides a full continuum of SUD benefits and has obtained a waiver of the IMD exclusion<\/p>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Integrated MMC plans: Majority of Medicaid population<\/li>\r\n\t<li>FFS: Spend-down population<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Outpatient services (ASAM 1)<\/li>\r\n\t<li>Intensive outpatient services (ASAM 2.1)<\/li>\r\n\t<li>Clinically managed low-intensity residential treatment services (ASAM 3.1)*<\/li>\r\n\t<li>Clinically managed population-specific high-intensity residential treatment services (ASAM 3.3)*<\/li>\r\n\t<li>Clinically managed high-intensity residential treatment services (ASAM 3.5)*<\/li>\r\n\t<li>Medically monitored intensive residential treatment services (ASAM 3.7)<\/li>\r\n\t<li>Ambulatory detoxification with extended on-site monitoring (ASAM 2-WM)<\/li>\r\n\t<li>Clinically managed residential social detoxification (ASAM 3.2-WM)*<\/li>\r\n\t<li>Medically monitored residential detoxification (ASAM 3.7-WM)*<\/li>\r\n\t<li>Medically managed inpatient therapies (ASAM 4-WM)*<\/li>\r\n\t<li>MAT<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n<ul>\r\n\t<li>Obtained waiver for SUD<\/li>\r\n\t<li>Requested but did not obtain waiver for MH<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>None<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval and SUD Implementation Plan; Original Waiver Application<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":27,"title":"Approved Through 12\/2021","states_id":20,"description":"SUD-Related Waiver Amendment Request Undergoing CMS Review","first_heading":"HealthChoice","second_heading":"Proposed Changes in HealthChoice Amendment","state_content":null,"state_name":"Maryland","medicad":[{"description":"<p>Waiver with SUD features approved on 12\/22\/2016; demonstration effective 1\/1\/2017 through 12\/31\/2021<\/p>","description2":"<p>Waiver amendment request with SUD features submitted to CMS on 6\/29\/2018; undergoing CMS review<\/p>","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration authorizes state&rsquo;s mandatory MMC program, among other features<\/li>\r\n\t<li>Includes SUD features aligned with July 2015 SMD letter; state provides a full continuum of SUD benefits and has obtained a waiver of the IMD exclusion<\/li>\r\n\t<li>Waives freedom of choice; individuals are required to obtain outpatient BH benefits from providers in public BH system<\/li>\r\n<\/ul>","description2":"<ul>\r\n\t<li>No proposed changes<\/li>\r\n<\/ul>","medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<p>ASO: Entire Medicaid population<\/p>","description2":"<p>No proposed changes<\/p>","medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Early intervention (ASAM 0.5)<\/li>\r\n\t<li>Outpatient services (ASAM 1)<\/li>\r\n\t<li>Intensive outpatient services (ASAM 2.1)<\/li>\r\n\t<li>Partial hospitalization (ASAM 2.5)<\/li>\r\n\t<li>Clinically managed low-intensity residential services (ASAM 3.1)^*<\/li>\r\n\t<li>Clinically managed population-specific highintensity residential services (ASAM 3.3)^*<\/li>\r\n\t<li>Clinically managed high-intensity residential services (ASAM 3.5)^*<\/li>\r\n\t<li>Medically monitored intensive inpatient services (ASAM 3.7)^*<\/li>\r\n\t<li>Medically managed intensive inpatient services (ASAM 4)<\/li>\r\n\t<li>Opioid maintenance therapy<\/li>\r\n\t<li>Office-based opioid treatment<\/li>\r\n\t<li>Ambulatory withdrawal management without extended on-site monitoring (ASAM 1-WM)<\/li>\r\n\t<li>Ambulatory withdrawal with extended onsite monitoring (ASAM 2-WM)<\/li>\r\n\t<li>Medically monitored inpatient withdrawal management (ASAM 3.7-WM)^*<\/li>\r\n<\/ul>","description2":"<ul>\r\n\t<li>Seeks to cover medically managed intensive inpatient services (ASAM 4) at IMDs<\/li>\r\n<\/ul>","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<p>Yes<\/p>\r\n<ul>\r\n\t<li>Obtained waiver for SUD for up to two stays of &le;30 days<\/li>\r\n<\/ul>","description2":"<p>Yes<\/p>\r\n<ul>\r\n\t<li>Requests to expand waiver to cover medically managed intensive inpatient services (ASAM 4) for individuals with a primary SUD diagnosis and a secondary mental health diagnosis for up to 15 days in a month<\/li>\r\n<\/ul>","medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>None<\/p>","description2":"<p>No proposed changes<\/p>","medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Original Waiver Application<\/p>","description2":"<p>Waiver Amendment Application<\/p>","medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":28,"title":"Approved Through 9\/2022","states_id":38,"description":null,"first_heading":"Pennsylvania Medicaid Coverage for Former Foster Care Youth From a Different State and SUD Demonstration","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Pennsylvania","medicad":[{"description":"<ul>\r\n\t<li>Waiver amendment with SUD features approved on 6\/28\/2018; demonstration effective 10\/1\/2017 through 9\/30\/2022<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration extends Medicaid eligibility to former foster care children ages 18&ndash;25 who moved from another state<\/li>\r\n\t<li>&nbsp;Includes SUD features aligned with November 2017 SMD letter; state provides a full continuum of SUD benefits and has obtained a waiver of the IMD exclusion (SUD features are not limited to former foster care youth)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>BH limited-benefit PIHPs: Majority of Medicaid population<\/li>\r\n\t<li>FFS: Populations excluded from BH limited-benefit PIHPs, including individuals enrolled in the 1915(c) Aging Waiver and individuals who reside in a state psychiatric hospital (outside the demonstration)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Outpatient services<\/li>\r\n\t<li>Intensive outpatient services<\/li>\r\n\t<li>Partial hospitalization (ASAM 2.5) (covered under 1915(b) authority)<\/li>\r\n\t<li>Halfway house (ASAM 3.1)* (covered under 1915(b) authority)<\/li>\r\n\t<li>Medically monitored short-term residential services (ASAM 3.5 or 3.7)* (covered under 1915(b) authority)<\/li>\r\n\t<li>Medically monitored long-term residential services (ASAM 3.5)* (covered under 1915(b) authority)<\/li>\r\n\t<li>Medically managed inpatient residential services (ASAM 4)*<\/li>\r\n\t<li>Medically monitored inpatient detoxification services (ASAM 3.7-WM)* (covered under 1915(b) authority)<\/li>\r\n\t<li>Medically managed inpatient detoxification services (ASAM 4-WM)*<\/li>\r\n\t<li>Recovery support services (covered under 1915(b) authority)*<\/li>\r\n\t<li>MAT*<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n\r\n<ul>\r\n\t<li>Obtained waiver for SUD for MMC enrollees<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>None<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval and SUD Implementation Plan; Waiver Amendment Application;<br \/>\r\n1915(b) MCO, PIHP Programs and FFS Selective Contracting Programs Waiver<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":29,"title":"Approved Through 6\/2022","states_id":21,"description":null,"first_heading":"MassHealth","second_heading":null,"state_content":"<p>As part of its September 2017 waiver amendment request, the state requested waiver of the IMD exclusion for<br \/>\r\nSUD and MH without the existing limitations; CMS denied this request.<br \/>\r\n^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Massachusetts","medicad":[{"description":"<p>Most recent waiver amendment approved on 6\/27\/2018; demonstration effective 6\/27\/2018 through 6\/30\/2022<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration authorizes mandatory enrollment in an MCO, ACO, or PCCM for majority of Medicaid population; other key features include a DSRIP initiative<\/li>\r\n\t<li>Authorizes enhanced &ldquo;diversionary&rdquo; BH services&mdash;HCBS BH services provided as alternatives or diversions from inpatient BH settings to community-based services&mdash;such as clinical support services for substance abuse, acute treatment services for substance abuse, and structured outpatient addiction programs<\/li>\r\n\t<li>As part of DSRIP, requires ACOs to establish linkages to BH community partners&mdash;CBOs that provide care management for enrollees with SMI, SED, and\/or SUD<\/li>\r\n\t<li>Waives IMD exclusion for a limited set of services<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Varies by populationEnrollees required to enroll in managed care choose one of the following options for BH services:&nbsp; &nbsp;<\/li>\r\n\t<\/ul><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; o Integrated MMC plan<\/p>\r\n    <p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;o Integrated ACO<\/p>\r\n   <p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;o BH limited-benefit PIHP<\/p>\r\n<ul>\r\n\t<li>FFS: Populations excluded from managed care, including individuals ages 65+ and individuals enrolled in PACE (outside the demonstration, with the exception of certain services delivered to individuals in IMDs)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Community support program^<\/li>\r\n\t<li>Acute treatment services for substance abuse^*<\/li>\r\n\t<li>Clinical support services for substance abuse^*<\/li>\r\n\t<li>Structured outpatient addiction program^<\/li>\r\n\t<li>Intensive outpatient program^<\/li>\r\n\t<li>Clinically managed low-intensity residential services, including 24-hour transitional support services, 24-hour residential rehabilitation services, and 24-hour communitybased family SUD treatment services (ASAM 3.1)^*<\/li>\r\n\t<li>Clinically managed population-specific high-intensity residential services (ASAM 3.3)^*<\/li>\r\n\t<li>Recovery support navigator services^<\/li>\r\n\t<li>Recovery coach services^ (available to ACO\/MCO enrollees only)<\/li>\r\n\t<li>Intensive outpatient program^<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n<ul>\r\n\t<li>Obtained waiver for MH and SUD limited to the services listed below:6 o Acute treatment services for substance abuse^*<\/li>\r\n<\/ul>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;o Clinical support services for substance abuse^*<\/p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; o Transitional care unit services^*<\/p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; o Clinically managed low-intensity residential services, including 24-hour transitional&nbsp; support services, 24-hour residential rehabilitation services, and 24-hour community-based family SUD treatment services (ASAM 3.1)^*<\/p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;o Clinically managed population-specific high-intensity residential services (ASAM 3.3)^*<\/p>\r\n<ul>\r\n\t<li>Waiver funding is authorized through Safety Net Care Pool and is capped<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<p>Enhanced diversionary BH services targeted toward MH include ACT, psychiatric day treatment, and community crisis stabilization<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Waiver Amendment Application; Waiver Extension and Amendment Application<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":30,"title":"Waiver Request Undergoing CMS Review","states_id":33,"description":null,"first_heading":"North Carolina\u2019s Medicaid Reform Demonstration","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"North Carolina","medicad":[{"description":"<p>Waiver request with SUD features submitted to CMS on 11\/20\/2017; undergoing CMS review<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration seeks to implement mandatory MMC for the majority of the Medicaid population, among other features<\/li>\r\n\t<li>&nbsp;Seeks to create specialized managed care products for enrollees with significant BH needs, I\/DDs, and TBIs that are called behavioral health and intellectual\/developmental disability (BH I\/DD) tailored plans<\/li>\r\n\t<li>&nbsp;Proposes including SUD features aligned with November 2017 SMD letter; state proposes offering a full continuum of SUD services and seeks a waiver of the IMD exclusion<\/li>\r\n\t<li>Requests comparability waiver to offer more intensive BH benefits, including intensive SUD residential services, only to individuals in BH I\/DD tailored plans<\/li>\r\n\t<li>&nbsp;Seeks expenditure authority to provide funding to support BH I\/DD tailored plans, care management agencies, and providers build capacity (e.g., IT and workforce) to implement BH and I\/DD-focused health homes<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Years 1 and 2 of managed care implementation:<\/li>\r\n\t<li>&nbsp;Integrated MMC plans (standard plans): Majority of Medicaid population<\/li>\r\n\t<li>&nbsp;BH limited-benefit PIHPs: Qualifying individuals with SMI, SED, SUD, I\/DD or TBI; HCBS waiver enrollees; dual eligibles; and medically needy individuals<\/li>\r\n\t<li>&nbsp;FFS: Populations excluded from BH limited-benefit PIHPs, including children enrolled in CHIP with significant BH needs and legal aliens (outside the demonstration, with the exception of services provided to individuals in IMDs)<\/li>\r\n\t<li>Years 3+ of managed care implementation:<\/li>\r\n\t<li>&nbsp;Integrated MMC plans (standard plans and BH I\/DD tailored plans): Majority of Medicaid population, including qualifying individuals (including children enrolled in CHIP) with SMI, SED, SUD, or I\/DD<\/li>\r\n\t<li>FFS: Populations excluded from managed care, including medically needy individuals, certain HCBS waiver enrollees, and dual eligibles without significant BH needs or an I\/DD (outside the demonstration, with the exception of services provided to individuals in IMDs)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Substance abuse halfway house (ASAM 3.1)*<\/li>\r\n\t<li>Social setting detoxification (ASAM 3.2-WM)*<\/li>\r\n\t<li>&nbsp;Clinically managed population-specific high-intensity residential services (ASAM 3.3)* (BH I\/DD tailored plans only)<\/li>\r\n\t<li>&nbsp;Substance abuse nonmedical community residential treatment (ASAM 3.5)* (BH I\/DD tailored plans only)<\/li>\r\n\t<li>&nbsp;Substance abuse medically monitored community residential treatment (ASAM 3.7)*<\/li>\r\n\t<li>&nbsp;Nonhospital medical detoxification (ASAM 3.7 WM)* (BH I\/DD tailored plans only)<\/li>\r\n\t<li>&nbsp;Medically supervised or alcohol drug abuse treatment center (ADATC) detoxification crisis stabilization (ASAM 3.9-WM)*<\/li>\r\n\t<li>Medically managed intensive inpatient services (ASAM 4)*<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n\r\n<ul>\r\n\t<li>&nbsp;Requests waiver for SUD and MH<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>See information above regarding BH I\/DD tailored plans<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Original Waiver Application<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":31,"title":"Approved Through 3\/2021","states_id":32,"description":"SUD-Related Waiver Amendment Request Undergoing CMS Review","first_heading":"Medicaid Redesign Team Demonstration","second_heading":"Proposed Changes in Medicaid Redesign Team Demonstration Amendment","state_content":"<p>As part of its May 2017 waiver amendment request, the state requested to transition its 1915(c) waivers serving<br \/>\r\nchildren into its 1115 waiver. CMS denied this request and the 1915(c) waivers will operate concurrently with the<br \/>\r\n1115 demonstration.<br \/>\r\n^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"New York","medicad":[{"description":"<p>Most recent waiver amendment approved on<br \/>\r\n1\/19\/2017; demonstration effective 12\/7\/2016<br \/>\r\nthrough 3\/30\/2021<\/p>","description2":"<p>Most recent waiver amendment approved on<br \/>\r\n1\/19\/2017; demonstration effective 12\/7\/2016<br \/>\r\nthrough 3\/30\/2021<\/p>","medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration authorizes state&rsquo;s mandatory MMC program, DSRIP initiative, and specialized managed care products for adults ages 21+ with SMI or serious SUD (called Health and Recovery Plans, or HARPs), among other features<\/li>\r\n\t<li>HARP enrollees have access to an enhanced BH benefit package; benefits are tiered based on an enrollee&rsquo;s level of need<\/li>\r\n\t<li>&nbsp;Utilization of enhanced HARP services is subject to an annual dollar cap<\/li>\r\n\t<li>DSRIP initiative includes projects targeted toward addressing primary care\/BH integration and preventing substance abuse; safety net hospitals are lead entities and form networks of providers and CBOs<\/li>\r\n<\/ul>","description2":"<p>Seeks to carve BH benefits into integrated<br \/>\r\nMMC plans for individuals ages &lt;21 (see<br \/>\r\nadditional detail below)8<\/p>","medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Integrated MMC plans: Majority of Medicaid population ages 21+<\/li>\r\n\t<li>FFS: Individuals ages &lt;21 (within demonstration) and populations excluded from managed care, including spend-down populations and individuals receiving partial benefits, among others (outside of demonstration)<\/li>\r\n<\/ul>","description2":"<ul>\r\n\t<li>Seeks to transition SUD and MH benefits for individuals ages &lt;21 from FFS to integrated MMC plans; individuals ages &lt;21 will not enroll in HARP<\/li>\r\n\t<li>Individuals who are excluded or exempt from managed care, including foster care children in the placement of a voluntary agency and individuals age &lt;21 who are permanent residents of residential healthcare facilities, will continue to receive SUD services through FFS<\/li>\r\n<\/ul>","medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>HARP enhanced benefits include:<\/li>\r\n\t<li>&nbsp;BH HCBS assessment^<\/li>\r\n\t<li>&nbsp;Empowerment services&mdash;peer supports^<\/li>\r\n\t<li>&nbsp;Habilitation services^<\/li>\r\n\t<li>&nbsp;Nonmedical transportation^<\/li>\r\n\t<li>&nbsp;Family support and training^<\/li>\r\n\t<li>&nbsp;Employment supports^<\/li>\r\n\t<li>Other benefits include:<\/li>\r\n\t<li>Inpatient and outpatient BH services, including chemical dependency services<\/li>\r\n\t<li>&nbsp;Residential addiction services^<\/li>\r\n\t<li>&nbsp;Outpatient addiction services^<\/li>\r\n\t<li>Crisis intervention^<\/li>\r\n\t<li>&nbsp;Licensed BH practitioner services^<\/li>\r\n\t<li>Medically supervised outpatient withdrawal<\/li>\r\n\t<li>Office of Alcoholism and Substance Abuse Services (OASAS) outpatient and opioid treatment program services<\/li>\r\n\t<li>&nbsp;OASAS outpatient rehabilitation programs<\/li>\r\n\t<li>&nbsp;Inpatient hospital: Medically managed detoxification (hospital-based)<\/li>\r\n\t<li>&nbsp;Inpatient hospital: Medically supervised inpatient detoxification<\/li>\r\n<\/ul>","description2":"<p>Residential rehabilitation services for youth<br \/>\r\n(carved out of managed care)<\/p>","medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>No<\/p>","description2":"<p>No proposed changes<\/p>","medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<ul>\r\n\t<li>HARP enhanced MH benefits include psychosocial rehabilitation, community psychiatric support and treatment, shortterm crisis respite, and intensive crisis respite<\/li>\r\n\t<li>&nbsp;DSRIP initiative includes projects targeted toward addressing primary care\/BH integration and MH promotion<\/li>\r\n<\/ul>","description2":"<p>See key SUD-related provisions above<\/p>","medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval<\/p>","description2":"<p>Waiver Amendment Application<\/p>","medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":32,"title":"Waiver Request Undergoing CMS Review","states_id":22,"description":null,"first_heading":"Pathway to Integration","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Michigan","medicad":[{"description":"<p>Waiver request with SUD features submitted to CMS on 6\/21\/2016; undergoing CMS review<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>BH- and I\/DD-focused waiver request seeking to combine authority for 1915(b) and 1915(c) waivers related to the delivery of BH and HCBS benefits<\/li>\r\n\t<li>Includes SUD features aligned with July 2015 SMD letter, proposes offering a full continuum of SUD benefits, and seeks a waiver of the IMD exclusion<\/li>\r\n\t<li>Seeks expenditure authority to implement alternative payment methodologies that promote physical and BH integration between PIHPs providing BH services and MMC plans providing physical health, acute care, and pharmacy services<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>BH limited-benefit PIHP: Majority of Medicaid population for most SUD services<\/li>\r\n\t<li>MMC plans providing physical health, acute care, and pharmacy services: Majority of Medicaid population for inpatient SUD treatment (ASAM 4 and ASAM 4-WM) \uf0a7 FFS: All SUD services for populations excluded from managed care, such as individuals in a nursing facility or ICF\/IID (outside the demonstration)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Early intervention (ASAM 0.5) \uf0a7 Outpatient therapy (ASAM 1)<\/li>\r\n\t<li>Intensive outpatient services (ASAM 2.1)<\/li>\r\n\t<li>Partial hospitalization (ASAM 2.5)<\/li>\r\n\t<li>Clinically managed low-intensity residential services (ASAM 3.1)<\/li>\r\n\t<li>Clinically managed population-specific high-intensity residential services (ASAM 3.3)<\/li>\r\n\t<li>Clinically managed high-intensity residential services (ASAM 3.5)<\/li>\r\n\t<li>Medically monitored intensive inpatient services (ASAM 3.7)<\/li>\r\n\t<li>Medically managed intensive inpatient services (ASAM 4)<\/li>\r\n\t<li>Ambulatory withdrawal management without extended on-site monitoring (ASAM 1-WM)<\/li>\r\n\t<li>Ambulatory withdrawal management with extended on-site monitoring (ASAM 2-WM)<\/li>\r\n\t<li>Clinically managed residential withdrawal management (ASAM 3.2-WM)<\/li>\r\n\t<li>Medically monitored inpatient withdrawal management (ASAM 3.7-WM)<\/li>\r\n\t<li>Medically managed intensive inpatient withdrawal management (ASAM 4-WM)<\/li>\r\n\t<li>Opioid treatment program, including MAT<\/li>\r\n\t<li>Targeted case management<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n<ul>\r\n\t<li>Requests waiver for SUD for MMC enrollees<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>Seeks to offer enhanced benefit package to individuals with SMI and SED, including HCBS benefits such as housing assistance and peer-directed and -operated support services<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Original Waiver Application; 1915(b) Michigan&rsquo;s Specialty Services and Supports Waiver; 1915(c) Waiver for Children With SED; 1915(c) Children&rsquo;s Waiver Program; 1915(c) Habilitation Supports Waiver<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":33,"title":"Waiver Request Undergoing CMS Review","states_id":23,"description":null,"first_heading":"Minnesota Substance Use Disorder System Reform 1115 Demonstration","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Minnesota","medicad":[{"description":"<p>Waiver request submitted to CMS on 5\/14\/2018; undergoing CMS review<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>SUD-focused waiver request aligned with November 2017 SMD letter; proposes offering a full continuum of SUD services and seeks a waiver of the IMD exclusion<\/li>\r\n\t<li>Seeks expenditure authority to reimburse providers that were participating in the Certified Community Behavioral Health Clinic (CCBHC) demonstration according to a cost-based payment structure (after the conclusion of the CCBHC demonstration)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Integrated MMC plans: Majority of Medicaid population<\/li>\r\n\t<li>FFS: Populations exempt or excluded from MMC, including individuals in the ABD eligibility group, spend-down populations, children with an SED (exempt), and adults with SPMI (exempt); services for FFS populations are funded through the Consolidated Chemical Dependency Treatment Fund 1915(b)(4) waiver and administered by counties and tribes<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Early intervention (SBIRT) (ASAM 0.5)<\/li>\r\n\t<li>Outpatient services (ASAM 1)<\/li>\r\n\t<li>Opioid treatment program (ASAM 1)<\/li>\r\n\t<li>Office-based opioid treatment (ASAM 1)<\/li>\r\n\t<li>Intensive outpatient service (ASAM 2.1)<\/li>\r\n\t<li>Partial hospitalization (ASAM 2.5)<\/li>\r\n\t<li>Clinically managed low-intensity residential services (ASAM 3.1)<\/li>\r\n\t<li>Clinically managed population-specific high-intensity residential services (ASAM 3.3)<\/li>\r\n\t<li>Clinically managed high-intensity residential services (ASAM 3.5)<\/li>\r\n\t<li>Medically monitored intensive inpatient services (ASAM 3.7)<\/li>\r\n\t<li>Medically managed intensive inpatient services (ASAM 4)<\/li>\r\n\t<li>Ambulatory withdrawal management without extended on-site monitoring (ASAM 1-WM)<\/li>\r\n\t<li>Ambulatory withdrawal management with extended on-site monitoring (ASAM 2-WM)<\/li>\r\n\t<li>Clinically managed residential withdrawal management (ASAM 3.2-WM)^*<\/li>\r\n\t<li>Medically managed inpatient withdrawal management (ASAM 3.7-WM)^*<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n<ul>\r\n\t<li>Requests waiver for SUD; waiver would be limited to providers participating in SUD provider networks that operate in accordance with ASAM standards<\/li>\r\n\t<li>Seeks match for up to two nonconsecutive stays of &le;30 days per year<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>See key SUD-related provisions above<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Original Waiver Application; Alcohol and Drug Abuse Services; Consolidated Chemical Dependency Treatment Fund 1915(b)(4) Waiver; Prepaid Minnesota Health Care Programs Manual: Education and Enrollment<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":34,"title":"Approved Through 12\/2018","states_id":31,"description":"SUD-Related Waiver Extension and Amendment Request Undergoing CMS Review","first_heading":"Centennial Care","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"New Mexico","medicad":[{"description":"<ul>\r\n\t<li>&nbsp;Most recent amendment (without SUD features) approved 11\/18\/2014; demonstration effective 1\/1\/2014 through 12\/31\/2018<\/li>\r\n\t<li>&nbsp;Waiver extension request with SUD features submitted to CMS on 12\/6\/2017; undergoing CMS review<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration authorizes state&rsquo;s mandatory MMC program, among other features<\/li>\r\n\t<li>Waiver extension and amendment request includes SUD features aligned with November 2017 SMD letter; state proposes offering a full continuum of SUD services and seeks a waiver of the IMD exclusion<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Integrated MMC plans: Majority of Medicaid population<\/li>\r\n\t<li>FFS: Populations excluded from managed care, including PACE enrollees, qualified Medicare beneficiaries, and individuals residing in an ICF\/IID (outside the demonstration, with the exception of services delivered to individuals in IMDs after approval of the waiver of the IMD exclusion)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<p>SBIRT (ASAM 0.5)<\/p>\r\n\r\n<ul>\r\n\t<li>&nbsp;Outpatient services (ASAM 1)<\/li>\r\n\t<li>&nbsp;Intensive outpatient services (ASAM 2.1)<\/li>\r\n\t<li>&nbsp;Partial hospitalization (ASAM 2.5)<\/li>\r\n\t<li>Residential treatment services (ASAM 3)*<\/li>\r\n\t<li>Inpatient services<\/li>\r\n\t<li>&nbsp;Medical detoxification<\/li>\r\n\t<li>&nbsp;Opioid treatment services<\/li>\r\n\t<li>&nbsp;MAT<\/li>\r\n\t<li>&nbsp;Recovery services<\/li>\r\n\t<li>Comprehensive community support services<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n\r\n<ul>\r\n\t<li>Requests waiver for SUD and MH<\/li>\r\n\t<li>Seeks match for up to 30 days of treatment<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>Seeks to offer peer-delivered pre-tenancy support services and tenancy support services to<br \/>\r\nindividuals with SMI<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Waiver Extension Application<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":35,"title":"Approved Through 12\/2022","states_id":25,"description":"SUD-Related Amendment Request Undergoing CMS Review","first_heading":"Gateway to Better Health","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"Missouri","medicad":[{"description":"<ul>\r\n\t<li>Most recent waiver extension (without SUD features) approved on 9\/1\/2017; demonstration effective 1\/1\/2018 through 12\/31\/2022<\/li>\r\n\t<li>Waiver amendment request with SUD features submitted to CMS on 8\/28\/2018; undergoing CMS review<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration authorizes limited coverage expansion for up to 21,342 uninsured individuals within incomes &le;100% FPL residing in St. Louis City or St. Louis County; State does not receive ACA&rsquo;s enhanced match for this population<\/li>\r\n\t<li>Costs are capped at $4.5 million\/year<\/li>\r\n\t<li>State uses funds that otherwise would have been spent on payments to disproportionate share hospitals to pay for limited coverage expansion<\/li>\r\n\t<li>Waiver amendment request seeks to add a limited set of SUD and MH services to Gateway to Better Health benefit package for enrollees with a SUD; coverage is not considered minimum essential coverage<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>FFS: Gateway to Better Health population; enrollees receive vouchers to use for care at limited set of providers (State obtained waiver of freedom of choice)<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Office visits for SUD treatment, including alcohol and drug treatment programs, group counseling for alcohol and drug treatment, case management, and self-help\/peer services \uf0a7 Generic prescriptions for SUD treatment<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>No<\/p>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>For individuals with SUD, State also seeks to cover office visits for MH services such as psychotherapy, MH partial hospitalization, and ACT<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Waiver Amendment Application<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":36,"title":"Approved Through 6\/2022","states_id":30,"description":null,"first_heading":"FamilyCare Comprehensive Demonstration","second_heading":null,"state_content":"<p>New Jersey has not yet transitioned all populations and services to the ASO. As the state undertakes this<br \/>\r\ntransition, SUD services are delivered through either a cost reimbursement model or FFS.<br \/>\r\n^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"New Jersey","medicad":[{"description":"<p>Waiver amendment request with SUD features approved on 10\/31\/2017; demonstration<br \/>\r\neffective 10\/31\/2017 through 6\/30\/2022<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration authorizes state&rsquo;s mandatory MMC program and DSRIP initiative, among other features<\/li>\r\n\t<li>DSRIP initiative includes projects targeted toward screening for SUDs, and increasing use of ED alternatives for individuals with alcohol intoxication; hospitals are lead entities<\/li>\r\n\t<li>Includes SUD features aligned with November 2017 SMD letter; state provides a full continuum of SUD benefits and has obtained a waiver of the IMD exclusion<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>ASO: Majority of Medicaid population for most SUD services7<\/li>\r\n\t<li>Physical health MCO: Majority of Medicaid population for a limited set of SUD services, such as detoxification in a medical bed<\/li>\r\n\t<li>Integrated MMC plan: Dual eligibles enrolled in a Medicare special needs plan and individuals enrolled in an MLTSS MCO<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<ul>\r\n\t<li>Early intervention (SBIRT)<\/li>\r\n\t<li>Outpatient services (ASAM 1)<\/li>\r\n\t<li>Intensive outpatient services (ASAM 2.1)<\/li>\r\n\t<li>Partial care services (ASAM 2.5)<\/li>\r\n\t<li>Long-term residential services (ASAM 3.5)*<\/li>\r\n\t<li>Short-term residential services (ASAM 3.7)*<\/li>\r\n\t<li>Ambulatory withdrawal management services (ASAM 2-WM)<\/li>\r\n\t<li>Withdrawal management services (ASAM 3.7-WM)*<\/li>\r\n\t<li>MAT*<\/li>\r\n\t<li>Peer support*<\/li>\r\n\t<li>Targeted case management*<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>Yes<\/p>\r\n\r\n<ul>\r\n\t<li>Obtained waiver for SUD<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<ul>\r\n\t<li>Expands Medicaid eligibility to youth &lt;age 21 with SED with incomes &le;150% FPL; population is eligible for limited benefit package including State Plan benefits and HCBS<\/li>\r\n\t<li>&nbsp;Expands Medicaid eligibility to youth &lt;age 21 with co-occurring I\/DD and mental illness with incomes &le;300% FPL; population is eligible for State Plan benefits and HCBS<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval; Original Waiver Application; SUD Implementation Plan<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]},{"id":37,"title":"Approved Through 12\/2020","states_id":29,"description":null,"first_heading":"Building Capacity for Transformation","second_heading":null,"state_content":"<p>^ = Only covered under demonstration<br \/>\r\n* = Eligible for match for individuals residing in an IMD<\/p>","state_name":"New Hampshire","medicad":[{"description":"<p>Waiver approved on 1\/5\/2016; demonstration effective 1\/5\/2016 through 12\/31\/2020<\/p>","description2":null,"medicaidquestions_id":5,"category_name":"Waiver Status"},{"description":"<ul>\r\n\t<li>Demonstration authorizes state&rsquo;s DSRIP initiative, which seeks to transform the state&rsquo;s BH delivery system through the creation of regionally based integrated delivery networks (IDNs) of behavioral health and other types of providers<\/li>\r\n\t<li>Requires IDNs to design and implement projects that:<\/li>\r\n<\/ul>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; o Increase community-based BH capacity; reduce unnecessary ED and inpatient utilization for BH conditions; and promote prevention of BH issues<\/p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;o Promote physical or virtual integration of physical and BH providers<\/p>\r\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;o Promote successful transitions of care and coordination across settings<\/p>\r\n<ul>\r\n\t<li>Requires IDNs to adopt alternative payment methodologies<\/li>\r\n\t<li>Creates IDN Transformation Fund to pay IDNs for meeting performance milestones<\/li>\r\n\t<li>Provides federal matching funds for BH-related DSHPs<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":6,"category_name":"Waiver Design Summary and Key SUD-Related Waiver Features"},{"description":"<ul>\r\n\t<li>Integrated MMC products: Majority of Medicaid population<\/li>\r\n\t<li>QHP premium assistance: Expansion adults (outside of demonstration; will transition to MMC in 2019)<\/li>\r\n\t<li>FFS: Children with SSI and spend-down populations, among others<\/li>\r\n<\/ul>","description2":null,"medicaidquestions_id":7,"category_name":"SUD Delivery System"},{"description":"<p>Not specified<\/p>","description2":null,"medicaidquestions_id":8,"category_name":"SUD Benefits Described in Waiver"},{"description":"<p>No<\/p>","description2":null,"medicaidquestions_id":9,"category_name":"Waiver of the IMD Exclusion"},{"description":"<p>See key SUD-related provisions above<\/p>","description2":null,"medicaidquestions_id":10,"category_name":"Other Notable MH-Related Provisions"},{"description":"<p>Demonstration Approval<\/p>","description2":null,"medicaidquestions_id":11,"category_name":"Reference Materials"}]}]